Nirsevimab (MEDI8897) is a recombinant human respiratory syncytial virus (RSV) monoclonal antibody with a modified Fc region, efficiently targeting RSV-B with a Kd value of 1.5 nM, and can be used to prevent RSV infection.
Purity:
98.10%
CAS Number:
[1989556-22-0]
Target:
RSV
* VAT and and shipping costs not included. Errors and price changes excepted